Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
Stock Information for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Loading
Please wait while we load your information from QuoteMedia.